Sign in
CompletedNo phase

Effect of Gluten-Free Dietary Education and Intraneural Facilitation® Therapy on Quality of Life in People With Diabetic Neuropathy

Key facts

Who runs it
Loma Linda University
Where
Loma Linda, United StatesSee the site
Trial code
Status
Completed
People taking part
46 people enrolled
Started
1 Aug 2023
Ended
20 May 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Intraneural Facilitation® Therapy (INF® Therapy)
  • INF® Therapy
Record updated
14 August 2025

Who can take part

Age
50 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • Participants in this study must be/have:
  • Older adults between 50 to 75 years of age
  • Willing to actively improve neuropathy symptoms
  • Diagnosed with Type II diabetes
  • Moderate to severe DPN (diabetic peripheral neuropathy) with symptoms below the knees of numbness, tingling, burning, sharp pain, and/or increased sensitivity
  • Distal Symmetric Polyneuropathy (DSPN) form of DPN
  • Independent in daily activities
  • Do not use any assistive device for walking such as a cane, walker, or wheelchair

Who cannot take part

  • Current regimen of chemotherapy, radiation, or dialysis
  • Documented active drug and/or alcohol misuse
  • Known allergy to chrome, nickel, or cobalt; Any of the following medical conditions:
  • End stage renal failure
  • End stage congestive heart failure
  • Uncontrolled hypertension
  • Chronic liver disease
  • Advanced chronic obstructive pulmonary disease
  • Other types of neuropathies not associated with diabetes including B12 deficiency
  • Any other chronic medical conditions requiring active treatment
  • Currently consuming a mainly plant-based or gluten-free diet
  • Lower extremity amputations and open wounds
  • Active inflammations
  • Morbid obesity
  • Pregnancy (self-reported)

Where in United States

  • Loma Linda University HealthLoma Linda, United States

About the trial

What the trial wants to find out

The purpose of this research is to compare the effectiveness of providing dietary education to complement Intraneural Facilitation® Therapy (INF® Therapy) (a physical therapy technique being evaluated that may help improve circulation) versus INF® Therapy only in adults with a type of neuropathy called distal symmetric polyneuropathy (DSPN).

The 2 groups in the trial

  • Intraneural Facilitation® Therapy (INF® Therapy) + Dietary EducationTreatment being tested

    The INF® Therapy+ group will receive dietary education with weekly follow-up by a physical therapist either in person, or via email or text message. The INF® Therapy+ group will additionally receive meal preparation ideas and sample menus promoting a gluten-free diet.

    Treatment: Intraneural Facilitation® Therapy (INF® Therapy)

  • Intraneural Facilitation® Therapy (INF® Therapy)Existing treatment, for comparison

    INF® Therapy is a manual therapy technique that consists of three components. The first is the pressurization or facilitation hold which biases circulation more consistently in the nerves, which is thought to "pressurize the entire system" The secondary hold attempts to stretch the innervated structure, pulling apart the tough dividing membrane and allowing the pressurized blood flow to transport from the outside "holding" chamber to the endoneurium and push open the closed capillary beds next to the nerve axons. Once capillaries surrounding the nerves are pressurized, the circulation needs to be induced up the neural connective tissue. A separate set of pressure points or "holds" are performed distal to the secondary holds to ensure the circulation is drawn up the inflamed capillary beds using the Bernoulli principle.

    Treatment: INF® Therapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
14 August 2025